| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.09 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |